Advances in Gerontology, 1 , 240-243
Not all compounding pharmacies are equal, and the differences can be significant
GLP-1RAs are now widely used and provide beneficial GLP-1R-mediated effects on glycemic control and body weight
Key Features High-purity lyophilized peptide Batch-specific Certificate of Analysis included Manufactured under strict quality standards Suitable for controlled laboratory research Packaged for professional handling environments Technical Specifications Compound: BPC-157 Format: Lyophilized powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory research In-vitro studies Biochemical analysis Preclinical model research Not intended for: Human or animal use Injection, ingestion, inhalation, or topical application Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada or any regulatory authority for clinical use
BMC Cancer 20, 954
The collective study cohort encompassed 1,028 participants assigned to the Tirzepatide group and 515 participants allocated to the Semaglutide group